Inventor · disambiguated record
Marian C. Bryan
Also filed as: BRYAN MARIAN · BRYAN MARIAN C
21 granted patents·4 pending applications·82 citations·filing 2007–2022
91Inventor score
Top patents by PatentIndex Score
25 records- 0194US8426447B2Spiro-tricyclic ring compounds as beta-secretase modulators and methods of useWHITE RYAN·Filed 2009·Granted Apr 23, 2013·58 cites·22 claims
- 0287US7635715B2Naphthalenone compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereofAMGEN INC·Filed 2007·Granted Dec 22, 2009·7 cites·50 claims
- 0386US9890152B2Aminopyrimidine compounds as inhibitors of T790M containing EGFR mutantsGENENTECH INC·Filed 2015·Granted Feb 13, 2018·7 cites·29 claims
- 0484US9951064B2Azaindazole compounds as inhibitors of T790M containing EGFR mutantsGENENTECH INC·Filed 2016·Granted Apr 24, 2018·5 cites·15 claims
- 0576US8048894B2Quinolones and azaquinolones that inhibit prolyl hydroxylaseAMGEN INC·Filed 2008·Granted Nov 1, 2011·2 cites·23 claims
- 0673US11945798B2Substituted aminopyridine compounds as EGFR inhibitorsYUHAN CORP·Filed 2022·Granted Apr 2, 2024·0 cites·39 claims
- 0772US12258328B26-membered heteroaryl-containing aminopyridine compounds as EGFR inhibitorsYUHAN CORP·Filed 2022·Granted Mar 25, 2025·0 cites·20 claims
- 0871US12258327B25-membered heteroaryl-containing aminopyridine compounds as EGFR inhibitorsYUHAN CORP·Filed 2022·Granted Mar 25, 2025·0 cites·25 claims
- 0970US8415376B2Inhibitors of PI3 kinaseBO YUNXIN Y·Filed 2009·Granted Apr 9, 2013·1 cites·9 claims
- 1069US8349868B2Azaquinolones that inhibit prolyl hydroxylaseAMGEN INC·Filed 2011·Granted Jan 8, 2013·1 cites·25 claims
- 1168US12247032B2Substituted pyrazolo[1,5-a]pyrimidines as inhibitors of JAK kinasesGENENTECH INC·Filed 2022·Granted Mar 11, 2025·0 cites·1 claims
- 1266US2022332718A1PYRAZOLO[1,5a]PYRIMIDINE DERIVATIVES AS IRAK4 MODULATORSGENENTECH INC·Filed 2021·Application pending·0 cites
- 1364US2023016791A1Inhalable dry powder and aerosol formulations of jak inhibitorsGENENTECH INC·Filed 2022·Application pending·0 cites
- 1463US8716281B2Pyrimidine compounds that inhibit anaplastic lymphoma kinaseBRYAN MARIAN C·Filed 2011·Granted May 6, 2014·1 cites·41 claims
- 1561US10988478B1Pyrazolo[1,5a]pyrimidine derivatives as IRAK4 modulatorsGENENTECH INC·Filed 2020·Granted Apr 27, 2021·0 cites·22 claims
- 1661US7928139B2Naphthalenone compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereofAMGEN INC·Filed 2009·Granted Apr 19, 2011·0 cites·30 claims
- 1757US11981658B2Substituted aminopyridine compounds as EGFR inhibitorsYUHAN CORP·Filed 2022·Granted May 14, 2024·0 cites·39 claims
- 1857US11453671B2Pyrazolopyrimidine inhibitors of JAK kinases and uses thereofGENENTECH INC·Filed 2020·Granted Sep 27, 2022·0 cites·12 claims
- 1957US2020399274A1Tetrazole-substituted pyrazolopyrimidine inhibitors of jak kinases and uses thereofGENENTECH INC·Filed 2020·Application pending·0 cites
- 2055US2018298015A1PYRAZOLO[1,5a]PYRIMIDINE DERIVATIVES AS IRAK4 MODULATORSGENENTECH INC·Filed 2018·Application pending·0 cites
- 2151US11034698B2Pyrazolo[ 1,5a]pyrimidine derivatives as IRAK4 modulatorsGENENTECH INC·Filed 2019·Granted Jun 15, 2021·0 cites·16 claims
- 2248US11434250B2Pyrazolo[1,5a]pyrimidine derivatives as IRAK4 modulatorsGENENTECH INC·Filed 2020·Granted Sep 6, 2022·0 cites·20 claims
- 2345US10899774B2IRAK4 modulatorsGENENTECH INC·Filed 2019·Granted Jan 26, 2021·0 cites·18 claims
- 2444US10899772B2IRAK4 modulatorsGENENTECH INC·Filed 2019·Granted Jan 26, 2021·0 cites·14 claims
- 2530US8431563B2Compounds that interact with glucokinase regulatory protein for the treatment of diabetesASHTON KATE·Filed 2011·Granted Apr 30, 2013·0 cites·34 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →